Imperative Care Secures Major Funding Round
Imperative Care, a medical technology company based in Campbell, California, has successfully closed a $100 million debt financing round. The company is focused on accelerating the development of technologies that aim to improve care for patients suffering from stroke and other severe vascular diseases.
Details of the Funding Round
The funding round, which took place on March 18, 2026, was led by Elevage Medical Technologies. Other participants in this round included Perceptive Advisors, Catalio Capital Management, Longaeva Partners, Brown Advisory, Ally Bridge Group, and Bain Capital Life Sciences.
Company Focus and Products
Imperative Care is at the forefront of medical technology, particularly in the treatment of thromboembolic diseases—conditions characterized by blood clot formations that can lead to serious health issues such as ischemic strokes. The company's product lineup includes the Zoom Stroke System, the Symphony Thrombectomy System, and the Prodigy Thrombectomy System. These products are designed to manage and treat blood clot-related conditions effectively.
In addition to its existing products, Imperative Care is developing the Telos robotic platform, an endovascular robotic system intended to enhance the precision and standardization of medical procedures, potentially expanding access to critical treatments.
Strategic Use of Funds
While specific plans for the newly acquired funds were not detailed in the announcement, it is likely that the company will use this capital to further develop its technology platforms and expand its product offerings. Given the focus on innovative solutions for stroke and vascular diseases, investments in research and development, as well as potential market expansion, could be anticipated.
Location and Contact
Imperative Care's operations are based in Campbell, California. For more information about their products and company initiatives, interested parties can visit their website.
This significant funding round underscores Imperative Care's commitment to advancing medical technology solutions that could play a critical role in improving patient outcomes for those suffering from severe vascular conditions.